These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23044980)

  • 1. Variation in use of high-cost diabetes mellitus medications in the VA healthcare system.
    Gellad W; Mor M; Zhao X; Donohue J; Good C
    Arch Intern Med; 2012 Nov; 172(20):1608-9. PubMed ID: 23044980
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementing high-value, cost-conscious diabetes mellitus care through the use of low-cost medications and less-intensive glycemic control target.
    Wilt TJ; Qaseem A
    Arch Intern Med; 2012 Nov; 172(20):1610-1. PubMed ID: 23044715
    [No Abstract]   [Full Text] [Related]  

  • 3. Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System.
    Gellad WF; Good CB; Lowe JC; Donohue JM
    Am J Manag Care; 2010 Oct; 16(10):741-50. PubMed ID: 20964470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in pharmaceutical treatment of diabetes and family financial burdens.
    Sarpong EM; Bernard DM; Miller GE
    Med Care Res Rev; 2012 Aug; 69(4):474-91. PubMed ID: 22513449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy costs and glycemic control in the Department of Veterans Affairs.
    Weinstock RS; Hawley G; Repke D; Feuerstein BL; Sawin CT; Pogach LM
    Diabetes Care; 2004 May; 27 Suppl 2():B74-81. PubMed ID: 15113787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost of diabetes mellitus in Spain].
    González P; Faure E; Del Castillo A;
    Med Clin (Barc); 2006 Nov; 127(20):776-84. PubMed ID: 17198665
    [No Abstract]   [Full Text] [Related]  

  • 7. Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery.
    Makary MA; Clark JM; Shore AD; Magnuson TH; Richards T; Bass EB; Dominici F; Weiner JP; Wu AW; Segal JB
    Arch Surg; 2010 Aug; 145(8):726-31. PubMed ID: 20713923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care.
    Piette JD; Wagner TH; Potter MB; Schillinger D
    Med Care; 2004 Feb; 42(2):102-9. PubMed ID: 14734946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic and clinical impact of innovative pharmacy benefit designs in the management of diabetes pharmacotherapy.
    Berger J
    Am J Manag Care; 2007 Apr; 13 Suppl 2():S55-8. PubMed ID: 17417934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct costs in diabetic and non diabetic people: the population-based Turin study, Italy.
    Bruno G; Picariello R; Petrelli A; Panero F; Costa G; Cavallo-Perin P; Demaria M; Gnavi R
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):684-90. PubMed ID: 21907553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes drugs in England cost nearly £1bn last year.
    Kmietowicz Z
    BMJ; 2016 Aug; 354():i4324. PubMed ID: 27492677
    [No Abstract]   [Full Text] [Related]  

  • 13. Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers.
    Maciejewski ML; Livingston EH; Kahwati LC; Henderson WG; Kavee AL; Arterburn DE
    Surg Obes Relat Dis; 2010; 6(6):601-7. PubMed ID: 20965791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
    Marković BB; Kranjcević K; Reiner Z; Blazeković SM; Spehar SS
    Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value-based insurance design for diabetes mellitus: approaches to optimal pharmacoeconomic implementation.
    Fendrick AM
    Am J Manag Care; 2010 Dec; 16(11 Suppl):S314-22. PubMed ID: 21517647
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-term medication cost savings for treating hypertension and diabetes after gastric bypass.
    Ghiassi S; Morton J; Bellatorre N; Eisenberg D
    Surg Obes Relat Dis; 2012; 8(3):269-74. PubMed ID: 21723203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new economics of diabetes management.
    Manag Care Interface; 2000; Suppl D():1-31. PubMed ID: 11187887
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
    Patel H; Srishanmuganathan J; Car J; Majeed A
    J Public Health (Oxf); 2007 Mar; 29(1):48-52. PubMed ID: 17124257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study.
    Tseng CW; Tierney EF; Gerzoff RB; Dudley RA; Waitzfelder B; Ackermann RT; Karter AJ; Piette J; Crosson JC; Ngo-Metzger Q; Chung R; Mangione CM
    Diabetes Care; 2008 Feb; 31(2):261-6. PubMed ID: 18000177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting].
    Jünger C; Rathmann W; Giani G
    Dtsch Med Wochenschr; 2000 Feb; 125(5):103-9. PubMed ID: 10705882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.